Epitopemapping by solution NMR spectroscopy

被引:36
作者
Bardelli, M. [1 ]
Livoti, E. [1 ]
Simonelli, L. [1 ]
Pedotti, M. [1 ]
Moraes, A. [2 ]
Valente, A. P. [2 ]
Varani, L. [1 ]
机构
[1] USI, Inst Biomed Res, Bellinzona, Switzerland
[2] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Rio De Janeiro, Brazil
关键词
NMR; antibodies; epitope mapping; LARGER PROTEINS; THERAPEUTIC-ANTIBODY; RESONANCE ASSIGNMENT; DOCKING; COMPLEX; MULTIDOMAIN; EPITOPES; EXCHANGE; ALLERGEN; SPECTRA;
D O I
10.1002/jmr.2454
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antibodies play an ever more prominent role in basic research as well as in the biotechnology and pharmaceutical sectors. Characterizing their epitopes, that is, the region that they recognize on their target molecule, is useful for purposes ranging from molecular biology research to vaccine design and intellectual property protection. Solution NMR spectroscopy is ideally suited to the atomic level characterization of intermolecular interfaces and, as a consequence, to epitope discovery. Here, we illustrate how NMR epitope mapping can be used to rapidly and accurately determine protein antigen epitopes. The basic concept is that differences in the NMR signal of an antigen free or bound by an antibody will identify epitope residues. NMR epitope mapping provides more detailed information than mutagenesis or peptide mapping and can be much more rapid than X-ray crystallography. Advantages and drawbacks of this technique are discussed together with practical considerations. Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:393 / 400
页数:8
相关论文
共 43 条
  • [1] Chemical exchange in NMR
    Bain, AD
    [J]. PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2003, 43 (3-4) : 63 - 103
  • [2] SINGLE-CHAIN ANTIGEN-BINDING PROTEINS
    BIRD, RE
    HARDMAN, KD
    JACOBSON, JW
    JOHNSON, S
    KAUFMAN, BM
    LEE, SM
    LEE, T
    POPE, SH
    RIORDAN, GS
    WHITLOW, M
    [J]. SCIENCE, 1988, 242 (4877) : 423 - 426
  • [3] One Target-Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1β
    Blech, Michaela
    Peter, Daniel
    Fischer, Peter
    Bauer, Margit M. T.
    Hafner, Mathias
    Zeeb, Markus
    Nar, Herbert
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2013, 425 (01) : 94 - 111
  • [4] Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications
    Blech, Michaela
    Seeliger, Daniel
    Kistler, Barbara
    Bauer, Margit M. T.
    Hafner, Mathias
    Hoerer, Stefan
    Zeeb, Markus
    Nar, Herbert
    Park, John E.
    [J]. BIOCHEMICAL JOURNAL, 2012, 447 : 205 - 215
  • [5] CLORE GM, 1994, PROG BIOPHYS MOL BIO, V62, P153
  • [6] STRUCTURES OF LARGER PROTEINS IN SOLUTION - 3-DIMENSIONAL AND 4-DIMENSIONAL HETERONUCLEAR NMR-SPECTROSCOPY
    CLORE, GM
    GRONENBORN, AM
    [J]. SCIENCE, 1991, 252 (5011) : 1390 - 1399
  • [7] Cortis D, 2013, ANN REV IMMUNOL, V31
  • [8] HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets
    De Vries, Sjoerd J.
    van Dijk, Aalt D. J.
    Krzeminski, Mickael
    van Dijk, Mark
    Thureau, Aurelien
    Hsu, Victor
    Wassenaar, Tsjerk
    Bonvin, Alexandre M. J. J.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 69 (04) : 726 - 733
  • [9] The HADDOCK web server for data-driven biomolecular docking
    De Vries, Sjoerd J.
    van Dijk, Marc
    Bonvin, Alexandre M. J. J.
    [J]. NATURE PROTOCOLS, 2010, 5 (05) : 883 - 897
  • [10] HADDOCK: A protein-protein docking approach based on biochemical or biophysical information
    Dominguez, C
    Boelens, R
    Bonvin, AMJJ
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (07) : 1731 - 1737